Home
Careers
Conferences
Directory
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Pharmaceutical Market Trends, 2008 - 2012: key market forecasts & growth opportunities
2.
Top-10 Biotech Companies - Market Outlook, 2008-2023
3.
Competitor Analysis: Janus Kinase (JAK) Inhibitors
4.
Enzyme Replacement & Enhancement Therapies (ERT)
5.
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
6.
The Cancer Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
7.
Protein Therapeutics Markets
8.
European Clinical Trial Site Options: An Insiders Analysis Overview
9.
Quality for Biologics
10.
Mammography World Markets
Best Sellers:
1.
Contract Research Annual Review 2008
2.
The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008
3.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
4.
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts The challenge of turning technology into therapy
5.
Orthopedics - Global Industry Guide
6.
Competitor Analysis: c-MET/HGF Inhibitors
7.
Competitor Analysis: Alzheimers Disease Antibodies
Commercial Opportunities for Enzyme Technologies, 3rd Edition
While the bulk of the business for enzymes is still serving the industrial market, the growth areas are increasing utilizing biotechnology. Revolutionary changes in molecular biology are churning out thousands of new uses of enzyme technology, fueling major growth in this multi-billion-dollar field.
D&MD's Commercial Opportunities in Enzyme Technologies, 3rd Edition examines the many current opportunities for enzymes as well as areas targeted for future growth. Specific attention is paid to the growing and various uses of enzymes over several industries from industrial uses to therapeutic targets. In addition, this Report profiles companies designing and producing enzymes, detailing their technologies and product pipelines.
> Detailed discussion of the process of engineering enzymes including lessons learned from protein engineering, helping you avoid common pitfalls.
> Thorough overview of the multiple uses of enzymes proving, the breadth of this technology and uncovering the most lucrative market opportunities
> A market analysis of Enzymes as commercial products, featuring discussions of the expanding fields of therapeutic enzymes, biologicals, and blood derivatives
> Speculation about the future growth opportunities of enzymes, including a full analysis of strategic issues facing the competitors in the Enzyme industry
> A thorough analysis of 50 companies involved with enzyme technologies, including patent summaries, providing a window into the enzyme playing field
Enzymes, the workhorses of various industrial processes, are gaining significant headway in the biotechnology and pharmaceutical industries. Industrial enzyme uses are evolving for the food processing, detergent, animal, feed and fuel alcohol markets. Some new uses include human enzymes as therapeutics, enzyme inhibitors used in therapy, and enzymes used in "green chemistry" and biocatalysis. Enzyme usage has also taken on a new synthetic life, as they are evolved to carry out reactions for which they were never "designed." It is abundantly clear that a bright, and competitive, future is in store for the use of enzymes.
Much progress has been made over the last five years in the engineering of enzymes through various techniques, from evolution to rational design. Learn about the latest enzyme production techniques when you order D&MD's Commercial Opportunities in Enzyme Technology, 3rd Edition.
Nov-06 Pages 302
List of Company Profiles
Price
PDF $4,950.00
Printed $5,150.00
CD-ROM $5,150.00
Single Site Licence $6,930.00
Global Site Licence $7,425.00
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.